|
|
|
|
| LEADER |
02657nam a2200493 4500 |
| 001 |
ocn828743739 |
| 003 |
OCoLC |
| 005 |
20180501122007.0 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
130212s2013 ne ad ob 001 0 eng d |
| 040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCO
|d OCLCQ
|d N$T
|d YDXCP
|d IDEBK
|d OPELS
|d OCLCF
|d GGVRL
|d OCLCQ
|d GrThAP
|
| 020 |
|
|
|a 9780444626714
|q (electronic bk.)
|
| 020 |
|
|
|a 0444626719
|q (electronic bk.)
|
| 020 |
|
|
|a 9780444626523
|
| 035 |
|
|
|a (OCoLC)828743739
|
| 050 |
|
4 |
|a RS403
|b .P76 2013eb
|
| 072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.19
|2 23
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Progress in medicinal chemistry.
|n Volume fifty two /
|c editors, G. Lawton, D.R. Witty.
|
| 250 |
|
|
|a 1st ed.
|
| 260 |
|
|
|a Amsterdam :
|b Elsevier,
|c 2013.
|
| 300 |
|
|
|a 1 online resource (xi, 245 pages) :
|b illustrations (some color).
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
0 |
|
|a Progress in medicinal chemistry,
|x 0079-6468 ;
|v v. 52
|
| 504 |
|
|
|a Includes bibliographical references and indexes.
|
| 520 |
|
|
|a Annual Review of Eclectic Developments in Medicinal Chemistry Progress in Medicinal Chemistry provides a review of eclectic developments in medicinal chemistry. This volume continues in the serial's tradition of providing an insight into the skills required of the modern medicinal chemist; in particular, the use of an appropriate selection of the wide range of tools now available to solve key scientific problems.
|
| 505 |
0 |
|
|a 1. Property-based design in the optimisation of benzamide glucokinase activators : from hit to clinic / Darren McKerrecher and Michael J. Waring -- 2. Medicinal chemistry of glucagon-like peptide receptor agonists / Lyn H. Jones and David A. Price -- 3. Antimalarial drug discovery : recent progress and future directions / Felix Calderon, David M. Wilson, and Francisco-Javier Gamo -- 4. Advances in the discovery of selective JAK inhibitors / Christel J. Menet, Luc Van Rompaey, and Raphael Geney.
|
| 650 |
|
0 |
|a Pharmaceutical chemistry.
|
| 650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
| 650 |
|
7 |
|a Pharmaceutical chemistry.
|2 fast
|0 (OCoLC)fst01060115
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Lawton, G.
|
| 700 |
1 |
|
|a Witty, D. R.
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/00796468/52
|z Full Text via HEAL-Link
|
